Paper33822285
Modifications of CD4 T cells, CD4/CD8 ratio and serum levels of soluble CD14 in HIV-HCV-coinfected patients after sustained HCV response induced by direct-acting antiviral agents: influence of liver cirrhosis.
Girón-Ortega JA and 5 others. Eur J Clin Microbiol Infect Dis, 2021. Cited by 8 papers, by iCite.
Cite this record
ConductScience Library. Modifications of CD4 T cells, CD4/CD8 ratio and serum levels of soluble CD14 in HIV-HCV-coinfected patients after sustained HCV response induced by direct-acting antiviral agents: influence of liver cirrhosis. Papers, record 33822285. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33822285
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
Modifications of CD4 T cells, CD4/CD8 ratio and serum levels of soluble CD14 in HIV-HCV-coinfected patients after sustained HCV response induced by direct-acting antiviral agents: influence of liver cirrhosis.
- PubMed
Topics15
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| CD4-Positive T-Lymphocytes | Major topic |
| CD8-Positive T-Lymphocytes | Major topic |
| Coinfection | Major topic |
| HIV Infections | Major topic |
| Hepacivirus | Major topic |
| Lipopolysaccharide Receptors | Major topic |
| Liver Cirrhosis | Major topic |
| CD4 Lymphocyte Count | |
| Female | |
| Hepatitis C | |
| Humans | |
| Male | |
| Middle Aged | |
| Sustained Virologic Response |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| No PI-0076-2017 | Secretaría General de Investigación, Desarrollo e Innovación en Salud, Junta de Andalucía, Iniciativa Territorial Integrada 2014-2020 para la provincia de Cádiz, Spain. Co-financed by FEDER (Fondo Europeo de Desarrollo Regional). | PubMed |
Source PubMed
References34
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 20479633 | Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy. | AIDS | 2010 | https://conductscience.org/library/papers/20479633 | PubMed |
| 2 | 28734831 | Effects of All-Oral Anti-Viral Therapy on HVPG and Systemic Hemodynamics in Patients With Hepatitis C Virus-Associated Cirrhosis. | Gastroenterology | 2017 | https://conductscience.org/library/papers/28734831 | PubMed |
| 3 | 21252259 | Plasma levels of soluble CD14 independently predict mortality in HIV infection. | J Infect Dis | 2011 | https://conductscience.org/library/papers/21252259 | PubMed |
| 4 | 24831517 | HIV-infected individuals with low CD4/CD8 ratio despite effective antiretroviral therapy exhibit altered T cell subsets, heightened CD8+ T cell activation, and increased risk of non-AIDS morbidity and mortality. | PLoS Pathog | 2014 | https://conductscience.org/library/papers/24831517 | PubMed |
| 5 | 22610932 | Sustained virological response to interferon plus ribavirin reduces non-liver-related mortality in patients coinfected with HIV and Hepatitis C virus. | Clin Infect Dis | 2012 | https://conductscience.org/library/papers/22610932 | PubMed |
| 6 | 15034063 | CD14 is an acute-phase protein. | J Immunol | 2004 | https://conductscience.org/library/papers/15034063 | PubMed |
| 7 | 25775475 | Immune activation response in chronic HIV-infected patients: influence of Hepatitis C virus coinfection. | PLoS One | 2015 | https://conductscience.org/library/papers/25775475 | PubMed |
| 8 | 28109003 | Eradication of hepatitis C virus and non-liver-related non-acquired immune deficiency syndrome-related events in human immunodeficiency virus/hepatitis C virus coinfection. | Hepatology | 2017 | https://conductscience.org/library/papers/28109003 | PubMed |
| 9 | 23429381 | Benefits from sustained virologic response to pegylated interferon plus ribavirin in HIV/hepatitis C virus-coinfected patients with compensated cirrhosis. | Clin Infect Dis | 2013 | https://conductscience.org/library/papers/23429381 | PubMed |
| 10 | 27371888 | CD4 and CD4/CD8 ratio progression in HIV-HCV infected patients after achievement of SVR. | J Clin Virol | 2016 | https://conductscience.org/library/papers/27371888 | PubMed |
| 11 | 29986086 | Eradication of Hepatitis C Virus (HCV) Reduces Immune Activation, Microbial Translocation, and the HIV DNA Level in HIV/HCV-Coinfected Patients. | J Infect Dis | 2018 | https://conductscience.org/library/papers/29986086 | PubMed |
| 12 | 16080095 | Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active antiretroviral therapy: a meta-analysis. | Clin Infect Dis | 2005 | https://conductscience.org/library/papers/16080095 | PubMed |
| 13 | 26819512 | Gut epithelial barrier dysfunction in human immunodeficiency virus-hepatitis C virus coinfected patients: Influence on innate and acquired immunity. | World J Gastroenterol | 2016 | https://conductscience.org/library/papers/26819512 | PubMed |
| 14 | 24717910 | Revised surveillance case definition for HIV infection--United States, 2014. | MMWR Recomm Rep | 2014 | https://conductscience.org/library/papers/24717910 | PubMed |
| 15 | 26424550 | CD4/CD8 ratio normalisation and non-AIDS-related events in individuals with HIV who achieve viral load suppression with antiretroviral therapy: an observational cohort study. | Lancet HIV | 2015 | https://conductscience.org/library/papers/26424550 | PubMed |
| 16 | 21505312 | Microbial translocation predicts disease progression of HIV-infected antiretroviral-naive patients with high CD4+ cell count. | AIDS | 2011 | https://conductscience.org/library/papers/21505312 | PubMed |
| 17 | 17879910 | The use of transient elastometry for assessing liver fibrosis in patients with HIV and hepatitis C virus coinfection. | Clin Infect Dis | 2007 | https://conductscience.org/library/papers/17879910 | PubMed |
| 18 | 24010646 | Effect of hepatitis C virus on immunological and virological responses in HIV-infected patients initiating highly active antiretroviral therapy: a meta-analysis. | J Viral Hepat | 2013 | https://conductscience.org/library/papers/24010646 | PubMed |
| 19 | 7903975 | Within-subject variation in CD4 lymphocyte count in asymptomatic human immunodeficiency virus infection: implications for patient monitoring. | J Infect Dis | 1994 | https://conductscience.org/library/papers/7903975 | PubMed |
| 20 | 7585150 | Failure of T-cell homeostasis preceding AIDS in HIV-1 infection. The Multicenter AIDS Cohort Study. | Nat Med | 1995 | https://conductscience.org/library/papers/7585150 | PubMed |
Cited by5
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 8 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40938627 | Role of immune cell subsets in liver fibrosis through single-cell RNA sequencing and array. | Cancer Biomark | 2025 | https://conductscience.org/library/papers/40938627 | PubMed |
| 40397618 | Hepatic Markers and Immunological Trajectories in a Cohort of Patients with HIV and Hepatitis C Virus Coinfection Treated with Direct-Acting Antivirals. | AIDS Res Hum Retroviruses | 2025 | https://conductscience.org/library/papers/40397618 | PubMed |
| 36777459 | Effect of Direct Antiviral Therapy Against HCV on CD4+ T Cell Count in Patients with HIV-HCV Coinfection. | HIV AIDS (Auckl) | 2023 | https://conductscience.org/library/papers/36777459 | PubMed |
| 35062255 | Variable Normalization of Naïve CD4+ Lymphopenia and Markers of Monocyte and T Cell Activation over the Course of Direct-Acting Anti-Viral Treatment of Chronic Hepatitis C Virus Infection. | Viruses | 2021 | https://conductscience.org/library/papers/35062255 | PubMed |
| 35047528 | The Model for End-Stage Liver Disease Score and the Follow-Up Period Can Cause the Shift of Circulating Lymphocyte Subsets in Liver Transplant Recipients. | Front Med (Lausanne) | 2021 | https://conductscience.org/library/papers/35047528 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| CD14 | 929 | PubTator's text mining | https://conductscience.org/library/genes/929 | NCBI Gene |
| CD4 | 920 | PubTator's text mining | https://conductscience.org/library/genes/920 | NCBI Gene |
| CD8A | 925 | PubTator's text mining | https://conductscience.org/library/genes/925 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33822285
GET https://conductscience.org/api/papers/v1/33822285/references?page=2